Immunisation schedule Victoria November 2021

1 For Recommended needle size and angle of needle insertion see page schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended. 1 of 6 *Live attenuated vaccine Risk conditionsAgeDiseaseVaccine brand ReconstituteSite givenRoute givenNotesBirthHepatitis BH-B-Vax-II paediatric or Engerix-B paediatric7 Anterolateral thighIMGive preferably within 24 hours of birth May be given up to 7 days after birth2 months (from 6 weeks) and 4 monthsDiphtheria-tetanus-pertussis, poliomyelitis-hepatitis B- Haemophilus influenzae type b Infanrix hexa3 Anterolateral thighIMPneumococcalPrevenar 137 Anterolateral thighIMRotavirusRotarix*7 MouthOral1st dose must be given before 15 weeks of age 2nd dose must be given before 25 weeks of ageAboriginal & torres strait Islander infantsMeningococcal BBexsero7 Anterolateral thighIMAge appropriate catch-up doses up to <2 years of age until 2023.

2 Give paracetamol in the 30 minutes before vaccination, or as soon as practicable after the vaccine. Followed by 2 more doses given 6 hours monthsDiphtheria-tetanus-pertussis- poliomyelitis-hepatitis B- Haemophilus influenzae type b Infanrix hexa3 Anterolateral thighIMGive with an 8-week interval after dose 2 of Infanrix hexa at minimum age of 24 months of age premature baby < 28 weeks gestation or with a risk conditionPneumococcalPrevenar 137 Anterolateral thighIMSee the online edition of The Australian Immunisation Handbook (handbook) for dosing schedule6 months to <5 years - all infants and children InfluenzaAs supplied7 Anterolateral thigh only if < 12 months of age IMAnnually. In children aged 6 months to less than 9 years of age in the first year of administration, give 2 doses a minimum of 1 month apart BCG for eligible infants and childrenTuberculosisAs supplied*BCG* for infants and children under 5 years of age travelling to TB endemic countriesFor more risk conditions and vaccinations see Additional at risk groups (page 6) Immunisation schedule Victoria November 2021 Infants and children *Live attenuated vaccine Risk conditionsFor Recommended needle size and angle of needle insertion see page schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.

3 2 of 6 *Live attenuated vaccine Risk conditionsImmunisation schedule Victoria November 2021 AgeDiseaseVaccine brand ReconstituteSite givenRoute givenNotes12 monthsMeasles-mumps- rubellaPriorix* or M-M-R-II*3 Anterolateral thigh/DeltoidIM/SCMeasles-mumps-rubella vaccines are the least reactogenic in this schedule pointMeningococcal ACWY Nimenrix3 DeltoidIMPneumococcalPrevenar 137 DeltoidIMAboriginal & torres strait Islander childrenMeningococcal BBexsero7 Anterolateral thigh/DeltoidIMAge appropriate catch-up doses up to <2 years of age until 2023. Give paracetamol in the 30 minutes before vaccination, or as soon as practicable after the vaccine. Followed by 2 more doses given 6 hours months of age premature baby < 32 weeks gestation or < 2000g birthweightHepatitis BH-B-Vax-II Paediatric or Engerix-B Paediatric7 Anterolateral thigh/DeltoidIMsingle booster doseAll children >12 months diagnosed with a risk conditionPneumococcalPrevenar 13 and Pneumovax 237 7 DeltoidIMSee online edition of the handbook for identification of people at increased risk and dosing schedule18 monthsMeasles-mumps-rubella-varicella (chickenpox)PriorixTetra* or ProQuad* 3 DeltoidIM/SCOnline edition of the handbook recommends 2nd dose of Varilrix /Varivax to reduce incidence of 'breakthrough' varicella.

4 This MUST be on prescription. Minimum 1 month interval for 2 live or Tripacel7 DeltoidIMHaemophilus influenzae type bActHIB3 Anterolateral thigh/DeltoidIMHaemophilus influenzae type b vaccine is the least reactogenic in this schedule point4 yearsDiphtheria-tetanus- pertussis-poliomyelitis Infanrix IPV or Quadracel7 DeltoidIM4 years of age with a risk conditionPneumococcalPneumovax 237 DeltoidIMSee online edition of the handbook for recommended dosing schedule5 years of age and over for all Aboriginal & torres strait Islander childrenInfluenzaAs supplied7 DeltoidIMIf less than 9 years of age in the first year of administration, give 2 doses a minimum of 1 month apart5 years of age and over with a risk conditionInfluenzaAs supplied7 DeltoidIMIf less than 9 years of age in the first year of administration, give 2 doses a minimum of 1 month apartFor more risk conditions and vaccinations see Additional at risk groups (page 6)Infants and children (cont.)

5 For Recommended needle size and angle of needle insertion see page schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended. 3 of 6 *Live attenuated vaccine Risk conditionsImmunisation schedule Victoria November 2021 AgeDiseaseVaccine brand ReconstituteSite givenRoute givenNotesYear 7 Secondary school (or age equivalent)Human papillomavirus (HPV)Gardasil 97 DeltoidIM2 dose course (0, 6-12m) under 15 years & 3 dose course (0, 2m, 6m) if 15 years and over. Major immunocompromising conditions require a 3 dose Year 10 Secondary School (or age equivalent)Meningococcal ACWYN imenrix3 DeltoidIM15 to 19 years of ageMeningococcal ACWYN imenrix3 DeltoidIMAll Aboriginal and torres strait Islanders InfluenzaAs supplied7 DeltoidIMAnnuallyAll adolescents diagnosed with a risk conditionInfluenza As supplied7 Deltoid IM Annually.

6 See online edition of the handbook for identification of people at increased risk. PneumococcalPrevenar 13 and Pneumovax 237 DeltoidIMSee online edition of the handbook for identification of people at increased risk and dosing more risk conditions and vaccinations see Additional at risk groups (page 6)Adolescents For Recommended needle size and angle of needle insertion see page schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended. 4 of 6 *Live attenuated vaccine Risk conditionsImmunisation schedule Victoria November 2021 AdultsAgeDiseaseVaccine brand ReconstituteSite givenRoute givenNotesAll adults diagnosed with a risk conditionPneumococcalPrevenar 13 Pneumovax 237 DeltoidIMSee online edition of the handbook for dosing schedule Aboriginal & torres strait Islanders InfluenzaAs supplied7 DeltoidIMAnnuallyHepatitis BEngerix (paediatric or adult)

7 7 DeltoidIMSee online edition of the handbook for dosing schedulePregnant womenInfluenzaAs supplied7 DeltoidIMAt any stage of pregnancyDiphtheria-tetanus-pertussisAda cel or Boostrix7 DeltoidIMPregnant women from 20 weeks gestation during every pregnancyPartners of women in the third trimester if the partner has not received the vaccine in the last 10 of a baby under 6 months of age and they have not received a pertussis booster in the last 10 with a risk conditionInfluenzaAs supplied7 DeltoidIMAnnually. See online edition of the handbook for identification of people at increased risk From 50 years of age Aboriginal & torres strait IslandersPneumococcalPrevenar 13 Pneumovax 237 7 Deltoid DeltoidIM IM See online edition of the handbook for identification of people at increased risk and dosing 65 years InfluenzaAs supplied7 DeltoidIMAnnually.

8 Preferentially use adjuvanted QIVFrom 70 yearsPneumococcalPrevenar 137 DeltoidIM70 years or from 71 to 79 years (until 31 October 2023)Shingles (Herpes Zoster)Zostavax*3 DeltoidSCSingle dose See online handbook for the Zostavax screening more risk conditions and vaccinations see Additional at risk groups (page 6)For Recommended needle size and angle of needle insertion see page schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended. 5 of 6 *Live attenuated vaccine Risk conditionsImmunisation schedule Victoria November 2021 Additional at risk groupsGroupDiseaseVaccine brand ReconstituteSite givenRoute givenNotesPeople of all ages with functional or anatomical asplenia, including sickle cell disease or other haemoglobinopathies, and congenital or acquired aspleniaPneumococcalPrevenar 13, Pneumovax 237 7 Anterolateral thigh/DeltoidIMSee online edition of the handbook for identification of people at increased risk and dosing B Meningococcal ACWYB exsero Nimenrix7 3 Anterolateral thigh/DeltoidIMSee online edition of the handbook for identification of people at increased risk and dosing influenzae type b (HiB)

9 ActHib3 Anterolateral thigh/DeltoidIMSee online edition of the handbook for identification of people at increased risk and dosing in, or deficiency of, complement components, including factor H, factor D or properdin deficiency & current/future treatment with eculizumabMeningooccal B Meningococcal ACWYB exsero Nimenrix7 3 Anterolateral thigh/DeltoidIMSee online edition of the handbook for identification of people at risk and dosing from 6 months and before 11 months of age prior to overseas travelMeasles-mumps-rubellaM-M-R-II*3 Anterolateral thigh IM/SCThis dose is in addition to the scheduled MMR vaccine doses usually administered at ages 12 (MMR) and 18 months (MMRV)Women planning pregnancy or after deliveryMeasles-mumps-rubellaM-M-R-II* 3 Deltoid IM/SCRubella non-immune women planning pregnancy or shortly after deliveryPeople born during or since 1966 Measles-mumps-rubellaM-M-R-II*3 Deltoid IM/SCOne or two doses is available for adults without evidence of receiving two documented doses of valid MMR vaccine or without serological evidence of immunityAll people under 20 years of ageAge appropriate vaccine catch-upAs suppliedAs applicableAs applicableAs applicableEligible for NIP and Victorian funded Immunisation programs.

10 The catch-up schedule will need to commence on or before the child s 20th birthday and may be completed beyond this date, as requiredAll refugees and humanitarian entrants including asylum seekersAge appropriate vaccine catch-upAs suppliedAs applicableAs applicableAs applicableEligible for NIP and Victorian funded Immunisation programs. This includes asylum seekers who may not be eligible for MedicareVulnerable citizensAge appropriate vaccine catch-upAs suppliedAs applicableAs applicableAs applicableEligible for NIP and Victorian funded Immunisation programsHepatitis B vaccine for eligible people at riskHepatitis BEngerix-B (paediatric /adult)7 DeltoidIMSee online edition of the handbook for dosing schedule .